Actualités et Activités de Relief Therapeutics
Présence
Relief Therapeutics fait partie des...
Relief Therapeutics est une société cotée sous le symbole boursier RLFTY (CH).
Dirigeants
Voir l'organigramme avec ses 8 principaux dirigeants
Biographies les plus recherchées chez Relief Therapeutics
- Raghuram Selvaraju, Chairman of the Board
- Vincenzo Gallo, Head of Legal and Compliance
- Christopher Wick, US Country Lead
Créer une alerte
pour suivre les mouvements de dirigeants chez Relief Therapeutics.
Biotechnologie
Relief Therapeutics a 2 350 concurrents dont Eurofins (Luxembourg), Lonza (Suisse) et Genus (Royaume—Uni).
Actualités en fusion/acquisition en Biotechnologie.
- Transcarent and Accolade have merged (publié le 9 avril 2025)..
- Kashiv BioSciences vient d'annoncer une levée de fonds de 150 millions de dollars. (publié le 7 avril 2025).
- Atsena Therapeutics vient d'annoncer une levée de fonds de 150 millions de dollars. (publié le 4 avril 2025).
Contacts en Biotechnologie
Actualités
Derniers communiqués de presse par Relief Therapeutics
- Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE®News Detail - Relief Therapeutics Holdings SA
- Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE®News Detail - Relief Therapeutics Holdings SA
- Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE®News Detail - Relief Therapeutics Holdings SA
- Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE®News Detail - Relief Therapeutics Holdings SA
- Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE®News Detail - Relief Therapeutics Holdings SA
- Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE®News Detail - Relief Therapeutics Holdings SA
- Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE®News Detail - Relief Therapeutics Holdings SA
- Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE®News Detail - Relief Therapeutics Holdings SA
- Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE®News Detail - Relief Therapeutics Holdings SA
- Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE®News Detail - Relief Therapeutics Holdings SA
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de Relief Therapeutics
- Relief Therapeutics sur Wikipédia, Google News & Yahoo Finance en 1-click
- Relief Therapeutics sur LinkedIn, Twitter & YouTube en 1-click
